Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 19, 1989 - Issue 8
30
Views
14
CrossRef citations to date
0
Altmetric
Research Article

The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat

, , , , &
Pages 913-925 | Received 22 Dec 1988, Accepted 23 Mar 1989, Published online: 22 Sep 2008
 

Abstract

1. The comparative gastric toxicology and pharmacokinetics of two phenoxyisobutyrate derivatives have been evaluated in the Fischer rat.

2. After oral administration of single daily doses for 7 days, the plasma elimination half-life for bezafibrate was rapid (t1/2 of 4–5 h) in comparison to ciprofibrate (t1/2 of 76 h).

3. The area under the plasma drug concentration versus time curve (AUC) 0–24 (μg± h/ml± SD) for bezafibrate (dose 125mg/kg per day) was 1553±334, which was less than half the value of 3748±358 achieved by ciprofibrate (10 mg/kg per day) after 7 days.

4. Oral administration of ciprofibrate at 10 mg/kg every 48 h produced similar sustained plasma concentrations to those achieved by bezafibrate 125 mg/kg dosed every 12 h. The AUC0–48 values (μg±h/ml±SD) achieved were 5124±450 for bezafibrate compared to 4207±240 for ciprofibrate.

5. In chronic oral multidose studies with ciprofibrate and bezafibrate, similar gastric toxicity (neuroendocrine cell hyperplasia) occurred in the rat when dose regimens were adjusted to compensate for the pharmacokinetic differences between these two drugs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.